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INTRODUCTION
During an action potential in striated muscle, the activation of ryanodine receptor channels (RyRs) induces the global Ca 2+ release from sarcoplasmic reticulum (SR) Ca 2+ stores triggering contraction (Bers, 2001; Fill and Copello, 2002; Fleischer, 2008; Sitsapesan and Williams, 1998) . The Ca 2+ released into the cytosol is rapidly sequestered back into the SR by the SR Ca 2+ ATPase (SERCA), leading to the relaxation of the muscle cells. The dynamics of Ca 2+ release events in muscle cells is complex and still not fully understood (Cheng and Lederer, 2008; Fill and Copello, 2002; Rios et al., 2008; Stern and Cheng, 2004) . Mitochondria appear to play an intricate role in the regulation of intracellular Ca 2+ , which includes structural and functional interactions with the SR and plasmalemma (Csordas and Hajnoczky, 2009; Lukyanenko et al., 2009; Rizzuto et al., 1998) . Among mitochondrial transporters, the CGP-37157
(CGP)-sensitive Na + /Ca 2+ exchanger (NCX) may mediate SR Ca 2+ load and release (Csordas and Hajnoczky, 2009; Malli et al., 2005; Szalai et al., 2000) . Indeed, CGP has been found to significantly affect intracellular Ca 2+ signaling in smooth, cardiac and skeletal muscle cells as well as in non-muscle systems (Belmonte and Morad, 2008; Chalmers and McCarron, 2009; Csordas and Hajnoczky, 2009; Griffiths et al., 1997; Liu and O'Rourke, 2008; Malli et al., 2005) .
The ability of the benzothiazepine derivative CGP to react with transporters other than the mitochondrial NCX (i.e., cross-reactivity), has not been fully explored. Reports have suggested that this compound can affect plasmalemma NCX (Czyz and Kiedrowski, 2003) and L-type Ca 2+ channels (Thu et al., 2006) . Various benzothiazepines with relatively different side chains, like K201 (Hunt et al., 2007;  MOL #67165
5 Kohno et al., 2003) and KN-326 (Kodama et al., 1988; Tatsukawa and Arita, 1997) , are known to modulate RyRs. K201 was also found to block the SERCA (Loughrey et al., 2007 
MATERIALS AND METHODS
Cardiac and skeletal SR microsomes
All animal procedures were designed to minimize pain and suffering and conformed to the guidelines of the National Institutes of Health. The committee on the Use and Care of Laboratory Animals of Southern Illinois University School of Medicine reviewed and approved the protocols for animal use. R2 and R4 fractions of skeletal muscle SR microsomes (eight different preparations) were isolated from predominantly fast-twitch skeletal muscle (back and leg; adult New Zealand white rabbits), as previously described (Chu et al., 1988; Saito et al., 1984) . For skeletal muscle, the R4 fraction of SR (TC microsomes) is highly enriched in terminal cisternae of SR, which consists of both the junctional face membrane of SR as well as the calcium pump membrane of SR. The Ryanodine Receptor of SR (RyR1) is localized to the junctional face membrane, whereas the Ca 2+ pump protein (Serca 1a) is localized in the calcium pump membrane of SR (Fleischer, 2008; Saito et al., 1984) . The R2 fraction of SR (LT microsomes) is referable to the longitudinal tubules of SR, which consists mainly of calcium pump membrane and is practically devoid of ryanodine receptor (Chu et al., 1988; Fleischer, 2008) . The LT microsomes are used to characterize the calcium pump, whereas the TC microsomes contain both RyR1 and SERCA 1a and therefore specific inhibitors for RyR1 and for the calcium pump must be used to sort out their response (Fleischer, 2008) .
Enriched porcine cardiac SR microsomes were prepared following protocols developed for dog heart SR microsomes (Chamberlain et al., 1983 CA) using the Ca 2+ -sensitive dye antipyrylazo III (APIII), as previously described (Chamberlain et al., 1984; Chu et al., 1988; Diaz-Sylvester et al., 2008 
Measurements of ATPase activity in SR microsomes
The effects of CGP (10 µM) were studied at 50 µM Ca 2+ which measures the effects of the drug on maximal SERCA ATPase rate (V max ). The data allows correlating the effects of CGP on initial rate of Ca 2+ load with ATPase activity. The effects of the drug were also measured in the presence of 300 nM Ca 2+ . These levels are close to the half-maximal activating Ca 2+ levels (K m ) of SERCA pump. We followed a protocol previously used in Dr. S. Fleischer laboratory (Chamberlain et al., 1984; Chu et al., 1988 (Chu et al., 1988) . The rate of ATP hydrolysis, in nmole ATP (mg SR protein) -1 min -1 was estimated from the equation:
This article has not been copyedited and formatted. The final version may differ from this version. ), L the cuvette length (in cm) and S the amount of SR protein added to the cuvette (mg/ml).
RyR channel recordings and data analysis
Cardiac and skeletal RyRs were reconstituted into planar lipid bilayers formed on 80-120 µm diameter circular holes in Teflon septa, separating two 1.2 ml compartments as previously described (Copello et al., 1997 This article has not been copyedited and formatted. The final version may differ from this version. The effects of CPG (10 µM) on SERCA were also assayed in skeletal muscle LT microsomes with an ATPase assay at two Ca 2+ concentrations. The first set was performed at a Ca 2+ concentration of 50 µM, where SERCA reaches maximal activity (V max ) and the second set was carried out with a Ca 2+ concentration of 300 nM, which is near the SERCA's half maximal activity (K m ) for Ca 2+ (Bers, 2001) . Figure 1E shows that with 50 µM Ca 2+ , approximately 95% of the ATPase of LT microsomes was blocked by 20 µM cyclopiazonic acid (CPZ), which inhibits SERCA. We also found that decreasing This article has not been copyedited and formatted. The final version may differ from this version. 
CGP activates skeletal and cardiac RyRs
In another set of experiments, we loaded skeletal muscle TC microsomes with Ca 2+ in the absence or presence of ruthenium red. Subsequently, the SERCA pump was inhibited by CPZ and the rate of Ca experiments (up to one hour in duration). CGP was cumulatively added to the cytosolic solution of RyR1 in the planar lipid bilayer to determine a half maximal effective concentration (EC 50 ) of 12.0 ± 3.5 μM. (n = 6 paired experiments Fig. 2D ). The effects of CGP were also studied on porcine cardiac RyR channels (RyR2). Figure 3A shows one RyR2 incubated with 1 µM cytosolic Ca 2+ (control). In this condition, the channel opened with moderate activity (P o = 0.16, estimated from 8-min recording). As shown in the figure, 2.5 µM CGP significantly activated the channel (P o = 0.49). With higher doses (20 µM), the channels were further activated (P o = 0.74). Figure 3B shows a dose response to cumulative doses of CGP to the cytosolic solution of RyR2 with a EC 50 of 9.4 ± 2.3 μM (n = 6 paired experiments). As suggested by the recordings, CGP changed the RyR2 kinetics. Dwell-time distributions show that the duration of openings significantly increased and the duration of closures greatly decreased (Fig. 3C ). As shown in the example of Fig. 3A , we found that the RyR2 remained active when [Ca 2+ ] cis was decreased to 100 nM, and that this effect was partially counteracted by the addition of 1 mM Mg 2+ . In absence of CGP, we found that the open probability of RyR2 at 100 nM is less than 5 % (absence of Mg 2+ ) or less than 1% (presence of Mg 2+ ), and as previously reported (Copello et al., 1997) . The effect of CGP on the channels was reversed after its removal from the cytosolic solution through superfusion.
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Comparison with other benzothiazepines
This is the first report on CGP direct modulation of RyRs. In this study, we found that CGP increased the activity of RyRs by stabilizing long-lasting opening events (EC 50~1 0-12.0 μM). In addition, CPG was also found to inhibit SERCA V max both in skeletal and cardiac muscle (IC 50 ~ 6.6 and 9.9 µM, respectively), without an apparent modification of the K m for Ca 2+ . Only one report tested CGP action on SERCA and found the drug at 10 µM was without significant action on ATP-ase activity of SR microsomes (Cox et al., 1993) .
Previous studies have shown that CGP, a clonazepam derivative, is an effective (IC 50 ~ 500 nM) and specific inhibitor of the mitochondrial NCX (Cox et al., 1993; Gunter and Pfeiffer, 1990 ). Yet, it was subsequently reported that CGP inhibits NCX in the plasmalemma (IC 50 ~ 13 μM) and blocks the L-type Ca 2+ channels (IC 50 ~ 0.27 μM) (Czyz and Kiedrowski, 2003; Thu et al., 2006) . Inhibition of plasmalemma NCX, L-type channels and SERCA has also been reported for clonazepam, the parent compound (Cox et al., 1993; Gershon, 1992; Griffiths et al., 1997) . Moreover, clonazepam is a wellThis article has not been copyedited and formatted. The final version may differ from this version. signaling in striated muscle. Some agents, like diltiazem, more specifically targets Ltype channels and only affect SERCA and RyRs at much higher doses (Chamberlain et al., 1984) . Other compounds of this class, such as KT-362, were termed "intracellular Ca 2+ channel antagonists" as they more specifically impair intracellular Ca 2+ release in vascular smooth muscle (Shibata et al., 1987; Ueyama et al., 1996) . Yet, for many of these compounds, the mechanism of action is still unclear. Two reports found that K201, also known as JTV519, inhibited RyRs, but they differ on the requirement of FK-506 binding protein for inhibition (Hunt et al., 2007; Wehrens et al., 2005) . However, an early study suggested that K201 could increase [ 3 H] ryanodine binding (Kohno et al., 2003) . In addition, others reported noticeable inhibitory action of K201 on ventricular myocytes whole cell Na + , Ca 2+ and K + currents, as well as on SERCA (James, 2007; Kimura et al., 1999 (Bers, 2001) . The process of mitochondrial Ca 2+ release that feeds the SR seems to be mediated by various transporters, including the mitochondrial NCX (Csordas and Hajnoczky, 2009; Malli et al., 2005; Szalai et al., 2000) . Reports have suggested that inhibition of the mitochondrial NCX by CGP results in significant depletion of SR Ca 2+ load (Csordas and Hajnoczky, 2009; Malli et al., 2005; Rizzuto et al., 1998 ). Yet, in those studies where SR depletion was manifest, and micromolar levels (ranging from 1 to 20 uM) of CGP were utilized.
Overall, this and previous studies demonstrate that micromolar levels of CGP would not only inhibit its most sensitive target (the mitochondrial NCX), but would also affect various other transporters known to significantly modulate intracellular Ca 2+ signaling and SR Ca 2+ content. From the inhibition of the SERCA pump activity and activation of RyRs, SR depletion and weakened excitation-contraction (EC) coupling would be expected (Bers, 2001 ). Inhibition of L-type Ca 2+ currents by CGP (Thu et al., 2006 ) may also be responsible for the SR Ca 2+ depletion, a process which has been observed with other L-type Ca 2+ channel blockers (Hussain and Orchard, 1997) .
Inhibition of the plasmalemma NCX by CGP (Czyz and Kiedrowski, 2003) would increase the SR Ca 2+ content under normal conditions, because this inhibition would increase the fraction of Ca 2+ that is sequester into SR by SERCA. However, NCX blockers are known to produce the opposite effect during reperfusion after ischemia, since the NCX works in a reverse mode (Ca 2+ influx) and inhibition would prevent Reports in the literature suggest that mitochondrial Ca 2+ efflux may play a deleterious role during cardiac ischemia, which can be prevented by CGP or clonazepam (Bonazzola and Takara, 2010; Csordas and Hajnoczky, 2009; Liu and O'Rourke, 2008) . A cardioprotective action has been reported for benzothiazepine derivatives (Farber and Gross, 1989; Wehrens et al., 2005) , as well as for many other drug classes and processes like preconditioning (Downey and Cohen, 2009 This may lead to a significant decrease in the energy expenditure of cells that may be beneficial under pathological conditions, like ischemia (Bonazzola and Takara, 2010) .
In summary, the literature is replete with studies suggesting that a mitochondrial NCX block by CGP results in intracellular Ca 2+ store depletion in various cell systems (Belmonte and Morad, 2008; Griffiths et al., 1997; Malli et al., 2005) . In this study, the nature of CGP interactions with SR transporters was explored and we found that there is direct CGP action on SERCA and RyRs. This report adds to a body of evidence that CGP targets other membrane transporters that play a key role in Ca 2+ homeostasis. The significant cross-reactivity of CGP with such a variety of molecular targets confounds the simple interpretation that the action of CGP, in intact cell Ca 2+ homeostasis, is due to block of the mitochondrial NCX.
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